Brief: Molecular Data Announces Fourth Quarter, Fiscal Year 2019 Unaudited Financial Results
March 25 (Reuters) - Molecular Data Inc MKD.O :
* . ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2019 UNAUDITED
FINANCIAL RESULTS
* Q4 REVENUE ROSE 38.1 PERCENT TO RMB 4.101 BILLION
* QTRLY LOSS PER SHARE RMB 0.54
* MOLECULAR DATA - COVID-19 PANDEMIC WOULD NEGATIVELY AFFECT
OVERALL FINANCIAL RESULTS IN Q1 2020
Source text for Eikon: urn:newsml:reuters.com:*:nGNX5Ycm1N
Further company coverage: MKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Molecular Data
See all newsBrief: Molecular Data Inc. Receives Nasdaq Notification
Brief: Molecular Data Inc. Announces Receipt Of Nasdaq Non-Compliance Letter
Brief: Molecular Data - On May 17, Received Delinquency Compliance Plan Alert Letter From Nasdaq
Brief: Molecular Data Inc Entered An Agreement To Form A Joint Venture To Build Supercomputing Clusters In North America
Brief: Mkd Sets Up JV In Electric Trucks Arena